Hong Kong Pharma Digital Technology Holdings Limited
HKPD
$1.44
-$0.03-2.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 21.72% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 21.72% | -- | -- | -- | |
| Cost of Revenue | 36.32% | -- | -- | -- | |
| Gross Profit | -32.13% | -- | -- | -- | |
| SG&A Expenses | 17.29% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | 2,150.00% | -- | -- | -- | |
| Total Operating Expenses | 33.98% | -- | -- | -- | |
| Operating Income | -88.60% | -- | -- | -- | |
| Income Before Tax | -97.64% | -- | -- | -- | |
| Income Tax Expenses | -67.82% | -- | -- | -- | |
| Earnings from Continuing Operations | -102.03% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -102.03% | -- | -- | -- | |
| EBIT | -88.60% | -- | -- | -- | |
| EBITDA | -84.65% | -- | -- | -- | |
| EPS Basic | -99.45% | -- | -- | -- | |
| Normalized Basic EPS | -88.14% | -- | -- | -- | |
| EPS Diluted | -99.81% | -- | -- | -- | |
| Normalized Diluted EPS | -88.14% | -- | -- | -- | |
| Average Basic Shares Outstanding | 72.35% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 33.72% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |